Angiosarcoma of the head and neck Journal Article


Authors: Lydiatt, W. M.; Shaha, A. R.; Shah, J. P.
Article Title: Angiosarcoma of the head and neck
Abstract: Background: Angiosarcoma (AS) is an uncommon, highly aggressive tumor with a poor prognosis. Methods: To study the impact of various treatment modalities, namely surgery, radiation, and chemotherapy, we reviewed our experience with AS of the head and neck. Results: From 1978 through 1992, we treated 13 men and 5 women with AS (median age 67 years). Sixteen tumors occurred on the scalp and face and 2 in the oropharynx. Two patients presented with cervical metastases, and a third had subsequent nodal involvement. Primary surgery was used in 9 patients, including 1 who received adjunctive systemic doxorubicin hydrochloride, and 2 who received adjunctive radiotherapy. The tumors of 9 patients were unresectable: 4 were treated with intra-arterial doxorubicin hydrochloride; and 5, with systemic doxorubicin hydrochloride. Twelve patients (67%) died of disease an average of 25 months after diagnosis. Overall 5-year survival was 33%, but only 20% of the patients were disease free. Size of the tumor was an important predictor of survival, as all patients with a lesion >10 cm died of disease, compared with 67% with a lesion <10 cm. Four of 6 patients treated with wide local excision for lesions <10 cm survived 5 years. Conclusions: We recommend surgery for resectable lesions with postoperative radiation for unsatisfactory margins, large tumor size, deep extension, and multicentricity. Elective treatment of the neck does not appear warranted. © 1994.
Keywords: adult; cancer survival; clinical article; aged; cancer surgery; survival rate; retrospective studies; cancer localization; doxorubicin; conference paper; cancer radiotherapy; combined modality therapy; tumor volume; angiosarcoma; hemangiosarcoma; head and neck cancer; head and neck neoplasms; human; male; female; priority journal
Journal Title: American Journal of Surgery
Volume: 168
Issue: 5
ISSN: 0002-9610
Publisher: Elsevier Inc.  
Date Published: 1994-11-01
Start Page: 451
End Page: 454
Language: English
DOI: 10.1016/s0002-9610(05)80097-2
PROVIDER: scopus
PUBMED: 7977971
DOI/URL:
Notes: Export Date: 14 January 2019 -- Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ashok R Shaha
    697 Shaha
  2. Jatin P Shah
    721 Shah
  3. William M. Lydiatt
    11 Lydiatt